Alprazolam in the Treatment of Anticipatory and Acute Situational Anxiety in Children with Cancer

Houston Zoo, Houston, Texas, United States
Journal of the American Academy of Child & Adolescent Psychiatry (Impact Factor: 7.26). 08/1987; 26(4):532-5. DOI: 10.1097/00004583-198707000-00012
Source: PubMed


A population of childhood cancer patients who undergo scheduled, periodic, stressful events such as bone marrow aspirations and spinal taps was chosen as a model for the investigation of the use of alprazolam in the treatment of anticipatory and acute situational anxiety in children. An open-label dose-ranging study was completed on 13 children. Because this was an early trial of a drug not approved for use in children, doses were low. Nonetheless, safe efficacious use of alprazolam was demonstrated and indicates that antianxiety agents may have a useful purpose for brief intervention situations in children.

5 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The GABA/benzodiazepine receptor chloride channel complex has been proposed to play a modulatory role in immune function. The effects of alprazolam, a triazolobenzodiazepine with high affinity for "central" benzodiazepine receptors, were examined on several parameters of immune function in mice. Natural killer cell activity, mixed leukocyte reactivity and mitogen-induced lymphocyte proliferation were all significantly increased two hr after administration of low doses (0.02-1.0 mg/kg) of alprazolam. Twenty four hr later, similar but less robust immunoenhancing effects were observed. Higher doses of alprazolam (5-10 mg/kg) did not affect these measures of immune function. The immunoenhancing effects of alprazolam did not appear related to corticosterone levels. In contrast, vehicle injection caused a profound suppression of these immune parameters two hr later, which was no longer apparent 24 hr later. This immunosuppression appeared to correlate with a concurrent rise in serum corticosterone levels. These data support the hypothesis that the GABA/benzodiazepine receptor chloride channel complex modulates immune function. Use of low doses of alprazolam may be of potential clinical importance when immunoenhancement is required.
    Life Sciences 02/1990; 47(26):2409-20. DOI:10.1016/0024-3205(90)90485-A · 2.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Two studies compared alprazolam and imipramine in the treatment of school refusal. In an open label study (N = 17), two-thirds of the subjects completing a trial in both the alprazolam and imipramine groups showed moderate to marked global improvement in symptoms of anxiety and depression. In the double-blind, placebo-controlled study (N = 24), posttreatment scores calculated as change from baseline on the Anxiety Rating for Children were significantly different (p = .03) among the three treatment groups, with the active medication groups showing the most improvement. Additionally, on all depression rating scales, similar trends were evident with the alprazolam and imipramine groups demonstrating greater improvement than the placebo group. However, analyses of covariance (with pretreatment scores as the covariates) showed no significant differences among the three treatment groups on change in anxiety and depression scales. Thus, additional research is needed to determine whether trends in this study are explained by drug effect or baseline differences on rating scales.
    Journal of the American Academy of Child & Adolescent Psychiatry 10/1990; 29(5):773-81. DOI:10.1097/00004583-199009000-00016 · 7.26 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The 1980s were a decade of advancement in the knowledge of anxiety disorders in children and adolescents; this sets the stage for research achievements in the 1990s. This review examines the anxiety disorders of childhood and adolescence (separation anxiety disorder, overanxious disorder, and avoidant disorder), including prevalence rates, demographic profiles, comparisons of clinical presentations in different developmental age groups, and comorbidity patterns. Fears and simple phobias, obsessive-compulsive disorder, post-traumatic stress disorder, and panic disorder in children and adolescents are also evaluated. The controversy of whether panic attacks occur in prepubertal children is addressed. A brief review of behavioral and pharmacological treatment studies is included. Future directions for research are suggested.
    Journal of the American Academy of Child & Adolescent Psychiatry 08/1991; 30(4):519-32. DOI:10.1097/00004583-199107000-00001 · 7.26 Impact Factor
Show more

Similar Publications